A Californian Cancer Killer -- Professor Yuman Fong and his work with Imugene episode artwork

EPISODE · Jul 27, 2023 · 26 MIN

A Californian Cancer Killer -- Professor Yuman Fong and his work with Imugene

from Vantage Point: Driving Success in the Australian Market · host NWR Communications

Professor Yuman Fong is co-inventor of the CF33 oncolytic virus, a technology that has been licensed to Imugene (ASX:IMU). He’s the Chairman of the Department of Surgery at City of Hope Cancer Centre in California. He’s an internationally recognised expert in pancreatic and liver cancer, as well as having developed many new surgical techniques and instruments. Ahead of his presentation as the keynote speaker at the Bioshares Biotech Summit, he joined us for episode 6 of NWR’s Vantage Point podcast.

Episode metadata supplied by the publisher feed · Published Jul 27, 2023

Embed this episode

NOW PLAYING

A Californian Cancer Killer -- Professor Yuman Fong and his work with Imugene

0:00 26:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Vantage Point: Driving Success in the Australian Market?

This episode is 26 minutes long.

When was this Vantage Point: Driving Success in the Australian Market episode published?

This episode was published on July 27, 2023.

Can I download this Vantage Point: Driving Success in the Australian Market episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!